Extension of Time to File SOU

SYMDAZYME

Genzyme Corporation

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88329923
LAW OFFICE ASSIGNED LAW OFFICE 128
MARK SECTION
MARK SYMDAZYME (see, http://uspto.report/TM/88329923/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SYMDAZYME
OWNER SECTION (current)
NAME Genzyme Corporation
MAILING ADDRESS 50 Binney Street
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Genzyme Corporation
MAILING ADDRESS 50 Binney Street
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Karen Lim
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) klim-docket@fzlz.com
DOCKET/REFERENCE NUMBER GENZ 1903727
CORRESPONDENCE INFORMATION (proposed)
NAME Karen Lim
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER GENZ 1903727
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 01/28/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /aude thrierr/
SIGNATORY'S NAME THRIERR Aude
SIGNATORY'S POSITION Authorized Signatory pursuant to a Power of Attorney
DATE SIGNED 07/01/2020
FILING INFORMATION
SUBMIT DATE Wed Jul 01 15:11:59 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XX-2
0200701151159022831-88329
923-710d8f31061a7c757d4bb
9b717b7f813c1fced3443d6ab
23d38e83b5c9f747931-DA-11
588225-202006260733532186
16



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: SYMDAZYME (see, http://uspto.report/TM/88329923/mark.png)
SERIAL NUMBER: 88329923

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Genzyme Corporation, having an address of
      50 Binney Street
      Cambridge, Massachusetts 02142
      United States
Proposed: Genzyme Corporation, having an address of
      50 Binney Street
      Cambridge, Massachusetts 02142
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 01/28/2020.

For International Class 005:
Current identification: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Karen Lim
      PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): klim-docket@fzlz.com

Correspondence Information (proposed):
      Karen Lim
      PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /aude thrierr/      Date Signed: 07/01/2020
Signatory's Name: THRIERR Aude
Signatory's Position: Authorized Signatory pursuant to a Power of Attorney

RAM Sale Number: 88329923
RAM Accounting Date: 07/01/2020

Serial Number: 88329923
Internet Transmission Date: Wed Jul 01 15:11:59 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XX-2020070115115902
2831-88329923-710d8f31061a7c757d4bb9b717
b7f813c1fced3443d6ab23d38e83b5c9f747931-
DA-11588225-20200626073353218616




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed